Tom Wu

1.8k total citations
27 papers, 1.1k citations indexed

About

Tom Wu is a scholar working on Molecular Biology, Immunology and Epidemiology. According to data from OpenAlex, Tom Wu has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Immunology and 5 papers in Epidemiology. Recurrent topics in Tom Wu's work include Immune Response and Inflammation (6 papers), Pancreatic function and diabetes (4 papers) and Immunotherapy and Immune Responses (3 papers). Tom Wu is often cited by papers focused on Immune Response and Inflammation (6 papers), Pancreatic function and diabetes (4 papers) and Immunotherapy and Immune Responses (3 papers). Tom Wu collaborates with scholars based in United States, Canada and Italy. Tom Wu's co-authors include Peter G. Schultz, Sheng Ding, Nathanael S. Gray, Wooyoung Hur, Achim Brinker, Eric C. Peters, Klaus W. Wagner, Badry Bursulaya, Quinn L. Deveraux and Denis Riendeau and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Cancer Research.

In The Last Decade

Tom Wu

26 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tom Wu United States 16 606 194 142 126 100 27 1.1k
Les P. Miranda United States 26 1.3k 2.1× 363 1.9× 138 1.0× 76 0.6× 49 0.5× 51 1.9k
Brian R. Hearn United States 17 811 1.3× 216 1.1× 78 0.5× 65 0.5× 91 0.9× 30 1.4k
Charles Day United States 17 664 1.1× 96 0.5× 64 0.5× 155 1.2× 149 1.5× 39 1.2k
Barbara Valsasina Italy 23 978 1.6× 173 0.9× 119 0.8× 94 0.7× 44 0.4× 42 1.5k
Daniel Gygax Switzerland 16 657 1.1× 136 0.7× 127 0.9× 36 0.3× 44 0.4× 42 1.1k
Anuradha S. Raghavan United States 12 1.0k 1.7× 293 1.5× 223 1.6× 62 0.5× 47 0.5× 15 1.4k
Alexander Pautsch Germany 15 1.8k 3.0× 121 0.6× 164 1.2× 59 0.5× 134 1.3× 22 2.7k
Li Niu United States 21 851 1.4× 84 0.4× 52 0.4× 57 0.5× 43 0.4× 62 1.3k
Karl F. Erhard United States 22 772 1.3× 262 1.4× 136 1.0× 62 0.5× 45 0.5× 43 1.4k
Yoshito Numata Japan 23 627 1.0× 172 0.9× 165 1.2× 29 0.2× 36 0.4× 46 1.2k

Countries citing papers authored by Tom Wu

Since Specialization
Citations

This map shows the geographic impact of Tom Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Wu more than expected).

Fields of papers citing papers by Tom Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Wu. The network helps show where Tom Wu may publish in the future.

Co-authorship network of co-authors of Tom Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Wu. A scholar is included among the top collaborators of Tom Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Wu. Tom Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chiang, Chih-Yuan, Douglas Lane, Tim Hoffman, et al.. (2022). A Novel Toll-Like Receptor 2 Agonist Protects Mice in a Prophylactic Treatment Model Against Challenge With Bacillus anthracis. Frontiers in Microbiology. 13. 803041–803041. 2 indexed citations
2.
Huang, Zhihong, Matthew S. Tremblay, Tom Wu, et al.. (2019). Discovery of 5-(3,4-Difluorophenyl)-3-(pyrazol-4-yl)-7-azaindole (GNF3809) for β-Cell Survival in Type 1 Diabetes. ACS Omega. 4(2). 3571–3581. 9 indexed citations
3.
Brito, Luis A., Tom Wu, Andrew T. Miller, et al.. (2018). Stable Nanoemulsions for the Delivery of Small Molecule Immune Potentiators. Journal of Pharmaceutical Sciences. 107(9). 2310–2314. 9 indexed citations
4.
Yang, Chengpeng, et al.. (2017). Investigation of Drug Cocktail Effects on Cancer Cell-Spheroids Using a Microfluidic Drug-Screening Assay. Micromachines. 8(6). 167–167. 13 indexed citations
5.
Wu, Tom. (2016). Strategies for designing synthetic immune agonists. Immunology. 148(4). 315–325. 25 indexed citations
6.
Hao, Xueshi, Qihui Jin, Porino Va, et al.. (2016). Pancreas‐Specific Delivery of β‐Cell Proliferating Small Molecules. ChemMedChem. 11(11). 1129–1132. 5 indexed citations
7.
Li, Yongkai, Andrew T. Miller, Xiaoyue Zhang, et al.. (2016). Incorporation of Phosphonate into Benzonaphthyridine Toll-like Receptor 7 Agonists for Adsorption to Aluminum Hydroxide. Journal of Medicinal Chemistry. 59(12). 5868–5878. 36 indexed citations
8.
Aprea, Susanna, Tom Wu, M. Cooke, et al.. (2015). A new TLR2 agonist promotes cross-presentation by mouse and human antigen presenting cells. Human Vaccines & Immunotherapeutics. 11(8). 2038–2050. 23 indexed citations
9.
Bufali, Simone, Tetsuo Uno, Tom Wu, et al.. (2014). Conjugation of a TLR7 agonist and antigen enhances protection in the S. pneumoniae murine infection model. European Journal of Pharmaceutics and Biopharmaceutics. 87(2). 310–317. 25 indexed citations
10.
Aspiotis, Renée, Austin Chen, Elizabeth Cauchon, et al.. (2011). The discovery and synthesis of potent zwitterionic inhibitors of renin. Bioorganic & Medicinal Chemistry Letters. 21(8). 2430–2436. 7 indexed citations
11.
Wu, Tom, Hélène Jûteau, Yves Ducharme, et al.. (2010). Biarylimidazoles as inhibitors of microsomal prostaglandin E2 synthase-1. Bioorganic & Medicinal Chemistry Letters. 20(23). 6978–6982. 29 indexed citations
12.
Aspiotis, Renée, Christopher I. Bayly, Austin Chen, et al.. (2010). Identification of a new biaryl scaffold generating potent renin inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(19). 5822–5826. 6 indexed citations
13.
Pulichino, Anne-Marie, Steve Rowland, Tom Wu, et al.. (2006). Prostacyclin Antagonism Reduces Pain and Inflammation in Rodent Models of Hyperalgesia and Chronic Arthritis. Journal of Pharmacology and Experimental Therapeutics. 319(3). 1043–1050. 94 indexed citations
14.
Wu, Tom & Sheng Ding. (2006). Applying chemical tools to the discovery of novel regenerative medicine. Drug Discovery Today Technologies. 3(3). 255–260. 3 indexed citations
15.
Luesch, Hendrik, Tom Wu, Pingda Ren, et al.. (2005). A Genome-Wide Overexpression Screen in Yeast for Small-Molecule Target Identification. Chemistry & Biology. 12(1). 55–63. 84 indexed citations
16.
Lowery, Thomas J., Sandra G. García, Eliseo Ruíz, et al.. (2005). Optimization of Xenon Biosensors for Detection of Protein Interactions. ChemBioChem. 7(1). 65–73. 73 indexed citations
17.
Ding, Sheng, Tom Wu, Achim Brinker, et al.. (2003). Synthetic small molecules that control stem cell fate. Proceedings of the National Academy of Sciences. 100(13). 7632–7637. 306 indexed citations
18.
Wu, Tom, Klaus W. Wagner, Badry Bursulaya, Peter G. Schultz, & Quinn L. Deveraux. (2003). Development and Characterization of Nonpeptidic Small Molecule Inhibitors of the XIAP/Caspase-3 Interaction. Chemistry & Biology. 10(8). 759–767. 93 indexed citations
19.
Wu, Tom, Christian A. Hassig, Yiqin Wu, Sheng Ding, & Peter G. Schultz. (2003). Design, synthesis, and activity of HDAC inhibitors with a N-formyl hydroxylamine head group. Bioorganic & Medicinal Chemistry Letters. 14(2). 449–453. 39 indexed citations
20.
Wu, Tom, Peter G. Schultz, & Sheng Ding. (2003). One-Pot Two-Step Microwave-Assisted Reaction in Constructing 4,5-Disubstituted Pyrazolopyrimidines. Organic Letters. 5(20). 3587–3590. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Les P. Miranda Breakdown of academic impact, for papers by Brian R. Hearn Breakdown of academic impact, for papers by Charles Day Breakdown of academic impact, for papers by Barbara Valsasina Breakdown of academic impact, for papers by Daniel Gygax Breakdown of academic impact, for papers by Anuradha S. Raghavan Breakdown of academic impact, for papers by Alexander Pautsch Breakdown of academic impact, for papers by Li Niu Breakdown of academic impact, for papers by Karl F. Erhard Breakdown of academic impact, for papers by Yoshito Numata
Rankless by CCL
2026